Jan C Buckner

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 3

Top Topics

Regulatory T Cells

Metastatic Colorectal Cancer

Top Venues

Neuro-oncology advances

Neuro-oncology practice

This page only lists publications with an associated author ORCID identifier.

Publications

Evanthia Galanis, S Keith Anderson, Erin Twohy, Nicholas A Butowski, Adilia Hormigo, David Schiff, Antonio Omuro, Kurt A Jaeckle, Shaji Kumar, Timothy J Kaufmann, Susan Geyer, Priya U Kumthekar, Jian Campian, Caterina Giannini, Jan C Buckner, Patrick Y Wen
Phase I/randomized phase II trial of TRC105 plus bevacizumab versus bevacizumab in recurrent glioblastoma: North Central Cancer Treatment Group N1174 (Alliance). Neuro-oncology advances 4 (1) (2022)
Ian F Parney, S Keith Anderson, Michael P Gustafson, Susan Steinmetz, Timothy E Peterson, Trynda N Kroneman, Aditya Raghunathan, Brian P O'Neill, Jan C Buckner, Mary Solseth, Allan B Dietz
Phase I trial of adjuvant mature autologous dendritic cell/allogeneic tumor lysate vaccines in combination with temozolomide in newly diagnosed glioblastoma. Neuro-oncology advances 4 (1) (2022)
Michael W Ruff, Jan C Buckner, Derek Richard Johnson, Martin J Van Den Bent, Marjolein Geurts
Neuro-Oncology Clinical Debate: PCV or temozolomide in combination with radiation for newly diagnosed high-grade oligodendroglioma. Neuro-oncology practice 6 (1) (2018)